rtki cpd and Brain Injuries

rtki cpd has been researched along with Brain Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrasco, M; Castro, C; Estrada, C; López-Toledano, MA; Murillo-Carretero, M; Romero-Grimaldi, C	1

Other Studies

1 other study(ies) available for rtki cpd and Brain Injuries

Article	Year
ADAM-17/tumor necrosis factor-α-converting enzyme inhibits neurogenesis and promotes gliogenesis from neural stem cells. Stem cells (Dayton, Ohio), 2011, Volume: 29, Issue:10 Topics: ADAM Proteins; ADAM17 Protein; Animals; Astrocytes; Brain Injuries; Cell Differentiation; Cell Proliferation; Dipeptides; Enzyme Activation; ErbB Receptors; Female; Immunohistochemistry; Intermediate Filament Proteins; Male; Mice; Nerve Tissue Proteins; Nestin; Neural Stem Cells; Neurogenesis; Neurons; Quinazolines; RNA, Messenger; RNA, Small Interfering; Transfection; Transforming Growth Factor alpha; Tyrphostins	2011

Article

Year

ADAM-17/tumor necrosis factor-α-converting enzyme inhibits neurogenesis and promotes gliogenesis from neural stem cells.

Stem cells (Dayton, Ohio), 2011, Volume: 29, Issue:10

Topics: ADAM Proteins; ADAM17 Protein; Animals; Astrocytes; Brain Injuries; Cell Differentiation; Cell Proliferation; Dipeptides; Enzyme Activation; ErbB Receptors; Female; Immunohistochemistry; Intermediate Filament Proteins; Male; Mice; Nerve Tissue Proteins; Nestin; Neural Stem Cells; Neurogenesis; Neurons; Quinazolines; RNA, Messenger; RNA, Small Interfering; Transfection; Transforming Growth Factor alpha; Tyrphostins

2011